Creating Next Generation

Smart Cell Therapies

Outpace is pushing the boundaries of biology to create tailored cell therapy solutions through protein design and custom programming.

 

Our Approach

Outpace is combining the design of improved biological functions and cellular control modalities to harness the full complexity of cellular biology to tackle incurable disease. We create mechanism-driven solutions tailor-made to dramatically improve efficacy and safety.

1/4
still_new_purchased_Tcell_video_shutters

The Right Solutions for
the Most Important Problems

We use our unique combination of protein design and cell engineering expertise to solve holy grail problems in cell and gene therapy. We use Rosetta, the most advanced protein design software in the world, to custom design new biological functions. Each solution adds new proteins to our physical platform with generalizable functions that we can repurpose to solve future problems. 

Outpace_tech_chart-22.png
Protein Design Platform
Physical Platform
Solutions
Design new biological functions
Outpace-owned proteins with
generalizable functions
Solutions to holy grail
problems in cell therapy
Outpace_Illustrations_-10.png
Ligand Redesign
Outpace_Illustrations_-11.png
Oligomerization and Orientation
Outpace_Illustrations_08_v3.png
Outpace_Illustrations_-12.png
Outpace_Illustrations_-13.png
Drug-induced Dimerization
Protein Actuator
Logic Gate

Our Platform

Outpace's technologies can modulate diverse biological functions using different control modalities, providing the opportunity to create the optimal solution. Our versatile platform can be applied across multiple problems in diverse areas of biology.

Outpace_Illustrations_09_v4.png
 

Pipeline

Outpace_Gantt_Chart_v3.png

Strategic collaborations with world-leading biotechnology and pharmaceutical companies are the cornerstone of the Outpace Business model. In addition to collaboratively developing assets for our partners' portfolios, we are also developing an internal pipeline as the foundation for future development.

 
 

Team

AllanWang_bw.jpg

Allan Wang

BradHammerson.jpg

Brad Hammerson

Jade Mimms

JosephDeSautelle_edited.jpg
LeahTait.png

Leah Tait

Robin Kirkpatrick

AndrewNg.png

Andrew Ng

BrianWeitzner.jpg

Brian Weitzner

JaredHammer_edited.jpg

Jared Hammer

Joshua Scheck

LesleyJones.png

Lesley Jones

RunfengMiao_edited.jpg

Runfeng Miao

AngieEmerson_edited_edited.jpg

Angie Emerson

EmilyBringgold.png

Emily Bringgold

JasonYokoyama_edited.jpg

Jason Yokoyama

KateMiller_edited.jpg

Kate Miller

MarcLajoie_headshot_black_and_white.jpg

Marc Lajoie

ScottBoyken.png

Scott Boyken

BobbyLangan.png

Bobby Langan

HowellMoffett.png

Howell Moffett

JenRunningDeer.png

Jen Running Deer

LauraBaker BW_edited.jpg

Laura Baker

Paul Sample

TadDavenport.png

Tad Davenport

Ty Crowl

Willimark Obenza_edited.jpg

Willimark Obenza

Board of Directors

VasBailey.png

Vasudev Bailey, PhD

Partner, Artis Ventures

ScottBoyken.png

Scott Boyken, PhD

CSO, Outpace Bio

MarcLajoie_headshot_black_and_white.jpg

Marc Lajoie, PhD

CEO, Outpace Bio

Investors

AV-25-25.png
Logos_Outpace_-29.png
Logos_Outpace_-26.png
Logos_Outpace_-30.png
Logos_Outpace_-27.png
Logos_Outpace_-34.png
Logos_Outpace_-28.png
Logos_Outpace_-35.png